Literature DB >> 25083482

The pros and cons of routine central compartment neck dissection for clinically nodal negative (cN0) papillary thyroid cancer.

Ai Chen Chan1, Brian Hung Hin Lang1, Kai Pun Wong1.   

Abstract

Metastatic disease to regional lymph nodes (LNs) is common in papillary thyroid carcinoma (PTC). LN dissection is increasingly performed as part of the surgical management of PTC. The role of prophylactic central neck dissection (pCND) in PTC is unclear. There is limited evidence to support a routine pCND in clinical setting for nodal negative (cN0) PTC. The aim of this review was to examine the pros and cons of prophylactic neck dissection in cN0 PTC. In summary, the advantages of pCND are: removal of the central LNs that potentially harbor micro-metastases, more accurate staging of disease in order to plan more individualized management, reducing the need for re-operation to remove the metastatic LNs which have developed later and possible improvement in overall survival. The disadvantages are: an extensive surgery but lack of evidence of survival benefit, higher incidence of complications with little impact on local recurrence rate, possibility of over treating in cN0 patients and it does not sound like a cost effective approach in the management of small thyroid cancer. Considering low frequency of permanent morbidity, some authors believe that prophylactic neck dissection is safe in experienced hands even though its prognostic benefit has yet to be demonstrated.

Entities:  

Keywords:  Central compartment neck dissection; nodal negative papillary thyroid cancer; prophylactic central neck dissection (pCND)

Year:  2013        PMID: 25083482      PMCID: PMC4115750          DOI: 10.3978/j.issn.2227-684X.2013.10.10

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  63 in total

1.  In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival.

Authors:  Mauricio A Moreno; Beth S Edeiken-Monroe; Eric R Siegel; Steven I Sherman; Gary L Clayman
Journal:  Thyroid       Date:  2012-01-26       Impact factor: 6.568

2.  Papillary cancer nodal surgery and the advisability of prophylactic central neck dissection: primum, non nocere.

Authors:  Gregory W Randolph
Journal:  Surgery       Date:  2010-12       Impact factor: 3.982

Review 3.  Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone.

Authors:  Edward J Chisholm; Elena Kulinskaya; Neil S Tolley
Journal:  Laryngoscope       Date:  2009-06       Impact factor: 3.325

4.  Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis.

Authors:  Tarek Zetoune; Xavier Keutgen; Daniel Buitrago; Hasan Aldailami; Huibo Shao; Madhu Mazumdar; Thomas J Fahey; Rasa Zarnegar
Journal:  Ann Surg Oncol       Date:  2010-07-02       Impact factor: 5.344

5.  Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.

Authors:  Mark Sywak; Lachlan Cornford; Paul Roach; Peter Stalberg; Stan Sidhu; Leigh Delbridge
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

6.  Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer.

Authors:  John M Stulak; Clive S Grant; David R Farley; Geoffrey B Thompson; Jon A van Heerden; Ian D Hay; Carl C Reading; J William Charboneau
Journal:  Arch Surg       Date:  2006-05

7.  Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.

Authors:  Brian Hung-Hin Lang; Chung-Yau Lo; Wai-Fan Chan; King-Yin Lam; Koon-Yat Wan
Journal:  Ann Surg Oncol       Date:  2006-11-11       Impact factor: 5.344

8.  Guidelines for radioiodine therapy of differentiated thyroid cancer.

Authors:  M Luster; S E Clarke; M Dietlein; M Lassmann; P Lind; W J G Oyen; J Tennvall; E Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10       Impact factor: 9.236

9.  Staging systems for papillary thyroid carcinoma: a study of 2 tertiary referral centers.

Authors:  Brian Hung-Hin Lang; Sin-Ming Chow; Chung-Yau Lo; Stephen C K Law; King-Yin Lam
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

10.  Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system.

Authors:  H Salvesen; P R Njølstad; L A Akslen; G Albrektsen; O Søreide; J E Varhaug
Journal:  Eur J Surg       Date:  1992 Nov-Dec
View more
  10 in total

Review 1.  Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.

Authors:  Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Carlos Suárez; Phillip K Pellitteri; Ashok R Shaha; Marc Hamoir; K Thomas Robbins; Avi Khafif; Juan P Rodrigo; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito; Dana M Hartl
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-11       Impact factor: 2.503

2.  Investigation of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma.

Authors:  Suzan Tabur; Şefika Nur Aksoy; Hakan Korkmaz; Mesut Ozkaya; Nurten Aksoy; Ersin Akarsu
Journal:  Tumour Biol       Date:  2014-12-02

3.  [Three-dimensional reconstruction of cervical CT vs ultrasound for estimating residual thyroid volume].

Authors:  Hongjuan Wang; Fei Chen; Yongquan Zhang; Zhichao Li; Ying Wang; Qiang Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-03-30

4.  Limitation of intraoperative frozen section during thyroid surgery.

Authors:  Sandrine Estebe; Cecile Montenat; Adrien Tremoureux; Chloé Rousseau; François Bouilloud; Franck Jegoux
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-02       Impact factor: 2.503

Review 5.  Morbidity of central neck dissection for papillary thyroid cancer.

Authors:  Davide Lombardi; Remo Accorona; Alberto Paderno; Carlo Cappelli; Piero Nicolai
Journal:  Gland Surg       Date:  2017-10

6.  Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients.

Authors:  Samuel Golpanian; Eduardo A Perez; Jun Tashiro; John I Lew; Juan E Sola; Anthony R Hogan
Journal:  Pediatr Surg Int       Date:  2015-12-30       Impact factor: 1.827

7.  Frozen section analysis of central lymph nodes in papillary thyroid cancer: the significance in determining the extent of surgery.

Authors:  Min Jhi Kim; Hee Jun Kim; Cheong Soo Park; Bup-Woo Kim
Journal:  Gland Surg       Date:  2022-04

8.  Role of sentinel node in differentiated thyroid cancer: a prospective study comparing patent blue injection technique, lymphoscintigraphy and the combined technique.

Authors:  R Gelmini; M Campanelli; F Cabry; A Franceschetto; G Ceresini; L Ruffini; A Zaccaroni; P Del Rio
Journal:  J Endocrinol Invest       Date:  2017-08-31       Impact factor: 4.256

9.  Are there disparities in the presentation, treatment and outcomes of patients diagnosed with medullary thyroid cancer?-An analysis of 634 patients from the California Cancer Registry.

Authors:  Christine Cox; Yingjia Chen; Rosemary Cress; Alison M Semrad; Thomas Semrad; Jessica E Gosnell; Michael J Campbell
Journal:  Gland Surg       Date:  2016-08

10.  To Identify Predictors of Central Lymph Node Metastasis in Patients with Clinically Node-Negative Conventional Papillary Thyroid Carcinoma.

Authors:  Jiru Yuan; Gang Zhao; Jialin Du; Xiaoyi Chen; Xiaodong Lin; Zhengbo Chen; Zeyu Wu
Journal:  Int J Endocrinol       Date:  2016-12-15       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.